Atezolizumab and hyaluronidase Brand names: Tecentriq

What is atezolizumab and hyaluronidase used for?

From the label: indications and usage

TECENTRIQ HYBREZA is a combination of atezolizumab, a programmed death-ligand 1 (PD-L1) blocking antibody, and hyaluronidase, an endoglycosidase indicated: Non-Small Cell Lung Cancer (NSCLC) as adjuvant treatment following resection and platinum-based chemotherapy for adult patients with Stage II to IIIA NSCLC whose tumors have PD-L1 expression on ≥ 1% of tumor cells, as determined by an FDA-authorized test. […]

Conditions named in the indications of atezolizumab and hyaluronidase's FDA labels, with every medicine labeled for each:

• Lung cancer

FDA pharmacologic class: Endoglycosidase and Programmed Death Receptor-1 Blocking Antibody.

What does the patient leaflet for atezolizumab and hyaluronidase say first?

The FDA-approved Medication Guide or Patient Information that comes with the medicine, in its own words.

From the patient leaflet: What is the most important information I should know about TECENTRIQ HYBREZA?

TECENTRIQ HYBREZA is a medicine that may treat certain cancers by working with your immune system. TECENTRIQ HYBREZA can cause your immune system to attack normal organs and tissues in any area of your body and can affect the way they work. These problems can sometimes become severe or life-threatening and can lead to death. You can have more than one of these problems at the same time. These problems may happen anytime during your treatment or even after your treatment has ended. […] These are not all of the signs and symptoms of immune system problems that can happen with TECENTRIQ HYBREZA. Call or see your healthcare provider right away for any new or worsening signs or symptoms, including: chest pain, irregular heartbeat, shortness of breath, swelling of ankles confusion, sleepiness, memory problems, changes in mood or behavior, stiff neck, balance problems, tingling or numbness of the arms or legs double vision, blurry vision, sensitivity to light, eye pain, changes in eyesight persistent or severe muscle pain or weakness, muscle cramps low red blood cells, bruising Infusion reactions that can sometimes be severe or life-threatening. […]

Is there a generic for atezolizumab and hyaluronidase (Tecentriq)?

No generic atezolizumab and hyaluronidase is approved (Drugs@FDA, October 8, 2026).

What does the atezolizumab and hyaluronidase label say about other medicines?

The atezolizumab and hyaluronidase label names 3 other medicines in its interaction, contraindication or warning sections. The sentences are the labels' own; a label lists what its studies and reports found, not every interaction.

Check atezolizumab and hyaluronidase against other medicines

What else is labeled for the same conditions as atezolizumab and hyaluronidase?

1 other medicine is given the same way (subcutaneous) and in the same FDA class as atezolizumab and hyaluronidase or labeled mainly for the same use (lung cancer), the same class first. Lung cancer lists all 55 medicines labeled for it, by any route. They are listed as records, not as substitutes: whether one can replace another is a prescriber's decision.

What next?

Other endoglycosidases

the pharmacologic class, with prices and generics

Check an interaction

what two or more labels say about each other